Emami Ltd-$ — earnings calls

Emami reported Q1 FY27 consolidated revenue growth of 15% to INR1,039 crores, with domestic business up 20% and international business declining 12% due to disruptions from the West Asia conflict. EBITDA grew 6% to INR226 crores and profit before tax grew 4% to INR195 crores, while profit after tax fell 16% to INR137 crores due to tax rate normalization. Management also introduced a new category-wise reporting framework, replacing brand-wise disclosure, and highlighted 61% like-to-like growth in its strategic investment portfolio comprising The Man Company, Brillare, Axiom and IncNut.

Emami reported consolidated Q4 FY26 revenue of Rs 925 crores, a 4% decline year-on-year, driven primarily by weakness in the summer portfolio including a 40% decline in talcum powders. Gross margins expanded to 68.4% while EBITDA fell 15% to Rs 187 crores due to operating deleverage, and the international business declined 5% on Middle East geopolitical disruptions. Management highlighted double-digit growth of 11% in the domestic business excluding the summer portfolio, growth in Kesh King, Pain Management and strategic investments, and discussed recent acquisitions including Axiom and IncNut.